Aboleris Pharma

Tolerance Bio, Inc.

This biopharmaceutical company develops thymus-based therapies to treat immune-mediated diseases including cancer, autoimmunity and transplant rejection for patients requiring restored immune tolerance.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Conveyor Therapeutics

This biotech company develops antibody drug conjugates to deliver immunosuppressive payloads for the treatment of immunological and inflammatory diseases in human patients.

Abologix

The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

COUR Pharma

This clinical-stage biotechnology company develops nanoparticle therapies designed to restore immune tolerance for patients with autoimmune and inflammatory diseases.